Prosecution Insights
Last updated: November 16, 2026
Application No. 18/793,823

NANOROBOT DESIGN, FUNCTION, AND FABRICATION PROCESS

Non-Final OA §101§102§112
Filed
Aug 04, 2024
Priority
Aug 05, 2023 — CIP of 63/517,901 +1 more
Examiner
DIETRICH, JOSEPH M
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Andrew Robert Haverly
OA Round
1 (Non-Final)
81%
Grant Probability
Favorable
1-2
OA Rounds
90%
With Interview

Examiner Intelligence

Grants 81% — above average
81%
Career Allowance Rate
769 granted / 948 resolved
+11.1% vs TC avg
Moderate +9% lift
Without
With
+8.8%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
45 currently pending
Career history
1004
Total Applications
across all art units

Office Action

§101 §102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1 – 20 are rejected under 35 U.S.C. 101 because the claimed invention is directed to non-statutory subject matter. The claim(s) does/do not fall within at least one of the four categories of patent eligible subject matter because the claims recite both a system and a process within the same claim. Please see MPEP 2106.03. Independent claim 1 recites: A system for nanorobots (The preamble indicates that this is a system claim which would fall under machine) comprising: a fabrication method (process); a power generator (machine); electrically controlled proteins (composition of matter); sensors (machine); and a method of killing an organism's cells (process); wherein a nanorobot is fabricated, put into the organism, powered, uses sensors to determine whether to kill the organism's cells, and selectively kills the organism's cells (method steps). A single claim cannot be both a system and a process of making and using the system. Because it is unclear whether infringement occurs when the device is made, when the proteins are provide, or only when the nanorobot itself is inserted and used to kill cells, the claim as a whole is not directed to a process, a machine, a manufacture, or a composition of matter. Claims 2 – 18 depend from claim 1 and do not cure the deficiencies of independent claim 1. Claims 19 and 20 use similar language and are similarly rejected. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1 – 20 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. As discussed above, it is unclear whether the claim as a whole is directed to a process, a machine, a manufacture, or a composition of matter. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1 – 20 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Shykind et al. (US PGPUB 2020/0319165). Regarding claim 1, Shykind discloses a system for nanorobots(e.g. ¶ 33) comprising: a fabrication method (e.g. ¶ 33); a power generator (e.g. Fig. 19 and ¶ 147); electrically controlled proteins (e.g. ¶ 7, 17, 23); sensors (e.g. ¶ 7, 8, 23); and a method of killing an organism's cells (e.g. ¶ 4, 24 – 26); wherein a nanorobot is fabricated, put into the organism, powered, uses sensors to determine whether to kill the organism's cells, and selectively kills the organism's cells (e.g. ¶ 6, 34). Regarding claim 2, Shykind discloses the fabrication method uses thin film transistors detached from their substrate (e.g. ¶ 101). Regarding claim 3, Shykind discloses the fabrication method fabricates the nanorobot on a silicon wafer and removes the excess silicon (e.g. Fig. 22 and ¶ 124). Regarding claims 4 – 7, Shykind discloses the power generator absorbs energy emitted from an outside device as claimed (e.g. ¶ 147). Regarding claim 8, Shykind discloses the power generator uses chemical processes to produce electric power (e.g. ¶ 124). Regarding claims 9 – 13, Shykind discloses the electrically controlled proteins are functionally disabled through controlled electrostatic inhibition as claimed (e.g. ¶ 148). Regarding claims 14 – 16, Shykind discloses the sensors are capable of detecting chemical properties of the nanorobot's surroundings as claimed (e.g. ¶ 131 – 133). Regarding claims 17 and 18, Shykind discloses the method of killing the organism's cells is performed by heating the nanorobot and/or by emitting ionizing radiation (e.g. ¶ 154). Regarding claim 19¸ Shykind discloses the system as previously mentioned, and further discloses the nanorobots can communicate with an outside device (e.g. ¶ 6). Regarding claim 20, Shykind discloses the system as previously mentioned, and further discloses nanorobots can release drugs (e.g. ¶ 121). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOSEPH M DIETRICH whose telephone number is (571)270-1895. The examiner can normally be reached Mon - Fri 8:00-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer McDonald can be reached at 571-270-3061. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JOSEPH M DIETRICH/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Aug 04, 2024
Application Filed
Sep 18, 2026
Non-Final Rejection mailed — §101, §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12788676
Implantable Electroacupuncture System and Method
3y 4m to grant Granted Nov 10, 2026
Patent 12788316
IMPLANTABLE RF SENSOR FOR BIOFILM DETECTION
3y 1m to grant Granted Nov 10, 2026
Patent 12788861
DEACTIVATION OF CIRCULATING TUMOR CELLS (CTCs) IN THE BLOODSTREAM BY ELECTROSTATIC STIMULATION OF THE PERIPHERAL BLOOD
1y 12m to grant Granted Nov 10, 2026
Patent 12788986
CONFIGURING A DEEP BRAIN STIMULATION (DBS) SYSTEM TO TREAT A NEUROLOGICAL DISORDER
1y 10m to grant Granted Nov 10, 2026
Patent 12778494
Systems And Methods For Holistic Habitual Improvement Via Digital Solutions
3y 4m to grant Granted Nov 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
81%
Grant Probability
90%
With Interview (+8.8%)
Low
PTA Risk
Based on 948 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month